FR2213778A1 - Adrenergics or hypoglycaemics for relieving skin disorders - e.g. psoriasis, dermatitis, skin carcinoma and acne in human beings - Google Patents

Adrenergics or hypoglycaemics for relieving skin disorders - e.g. psoriasis, dermatitis, skin carcinoma and acne in human beings

Info

Publication number
FR2213778A1
FR2213778A1 FR7401338A FR7401338A FR2213778A1 FR 2213778 A1 FR2213778 A1 FR 2213778A1 FR 7401338 A FR7401338 A FR 7401338A FR 7401338 A FR7401338 A FR 7401338A FR 2213778 A1 FR2213778 A1 FR 2213778A1
Authority
FR
France
Prior art keywords
adenosine
dermatitis
hypoglycaemics
adrenergics
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7401338A
Other languages
French (fr)
Other versions
FR2213778B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VOORHEES JOHN US
Original Assignee
VOORHEES JOHN US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VOORHEES JOHN US filed Critical VOORHEES JOHN US
Publication of FR2213778A1 publication Critical patent/FR2213778A1/en
Application granted granted Critical
Publication of FR2213778B1 publication Critical patent/FR2213778B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Abstract

Pharmaceutical compsns consisting of a pharmaceutical carrier and 0.1-15% w/v of (a) one of a wide variety of specified alpha-, beta-, or beta2-sympatholytic agents, (b) adenosine, 2'-deoxyadenosine, 2'-3'-isopropylideneadenosine, toyocamycin, 1-methyladenosine, N6-methyladenosine, adenosine N-oxide, 6-methyl-mercaptopurine riboside, 6-chloropurine, riboside or 5'-adenosine monophosphate, or (c) amantadine, tolbutamide, chlorpropamide, tolazamide, acetohexamide or phenformin, or their mixts afford relief from the symptoms of benign and malignant skin proliferation disorders characterised by accelerated cell division e.g. lamellar ichtyosis and keratoses in humans and atopic dermatitis and mange in animals. The compsns may be administered topically, orally, parenterally (e.g.i.m), or by intradermal, intra- or peri-lesional or subcutaneous injection.
FR7401338A 1973-01-16 1974-01-15 Adrenergics or hypoglycaemics for relieving skin disorders - e.g. psoriasis, dermatitis, skin carcinoma and acne in human beings Granted FR2213778A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32401273A 1973-01-16 1973-01-16
US42533873A 1973-12-17 1973-12-17

Publications (2)

Publication Number Publication Date
FR2213778A1 true FR2213778A1 (en) 1974-08-09
FR2213778B1 FR2213778B1 (en) 1978-01-06

Family

ID=26984235

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7401338A Granted FR2213778A1 (en) 1973-01-16 1974-01-15 Adrenergics or hypoglycaemics for relieving skin disorders - e.g. psoriasis, dermatitis, skin carcinoma and acne in human beings

Country Status (3)

Country Link
BE (1) BE809831A (en)
DE (1) DE2401450A1 (en)
FR (1) FR2213778A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809310A1 (en) * 2000-05-26 2001-11-30 Centre Nat Rech Scient USE OF BIGUANIDE DERIVATIVES FOR MANUFACTURING A MEDICAMENT HAVING A HEALING EFFECT
FR2826278A1 (en) * 2001-06-20 2002-12-27 Lipha Use of antidiabetic agents to promote wound healing, especially diabetic ulcers, applied topically to skin
WO2003003971A2 (en) * 2001-06-20 2003-01-16 Merck Sante Use of antidiabetics for making a medicine with cicatrizing effect
FR2894466A1 (en) * 2005-12-08 2007-06-15 Oreal Cosmetic composition, useful to attenuate skin wrinkles, comprises nonphosphate adenosine compound and filler

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45991B1 (en) * 1976-12-16 1983-01-26 Ici Ltd Esters of hydroxy amino amides
PH25150A (en) * 1986-06-05 1991-03-13 Ciba Geigy Ag Novel pharmaceutical preparation for topical application
DE19545107A1 (en) * 1995-12-04 1997-06-05 Beiersdorf Ag Use of adenosine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2038102A1 (en) * 1969-04-01 1971-01-08 Draco Ab
FR2052969A1 (en) * 1969-06-13 1971-04-16 Draco Ab

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2038102A1 (en) * 1969-04-01 1971-01-08 Draco Ab
FR2052969A1 (en) * 1969-06-13 1971-04-16 Draco Ab

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809310A1 (en) * 2000-05-26 2001-11-30 Centre Nat Rech Scient USE OF BIGUANIDE DERIVATIVES FOR MANUFACTURING A MEDICAMENT HAVING A HEALING EFFECT
WO2001091696A2 (en) * 2000-05-26 2001-12-06 Centre National De La Recherche Scientifique (Cnrs) Use of biguanide derivatives for making a medicine having a wound healing effect
WO2001091696A3 (en) * 2000-05-26 2002-06-06 Centre Nat Rech Scient Use of biguanide derivatives for making a medicine having a wound healing effect
US7199159B2 (en) 2000-05-26 2007-04-03 Centre National De La Recherche Scientifique (C.N.R.S.) Use of biguanide derivatives for making a medicine having a wound healing effect
CN100420439C (en) * 2000-05-26 2008-09-24 国家科研中心 Use of biguanide derivatives for making a medicine having a wound healing effect
BG65847B1 (en) * 2000-05-26 2010-03-31 Centre National De La Recherche Scientifique Use of biguanide derivatives for making a medicine having a wound healing effect
FR2826278A1 (en) * 2001-06-20 2002-12-27 Lipha Use of antidiabetic agents to promote wound healing, especially diabetic ulcers, applied topically to skin
WO2003003971A2 (en) * 2001-06-20 2003-01-16 Merck Sante Use of antidiabetics for making a medicine with cicatrizing effect
WO2003003971A3 (en) * 2001-06-20 2003-12-04 Merck Sante Sas Use of antidiabetics for making a medicine with cicatrizing effect
FR2894466A1 (en) * 2005-12-08 2007-06-15 Oreal Cosmetic composition, useful to attenuate skin wrinkles, comprises nonphosphate adenosine compound and filler

Also Published As

Publication number Publication date
DE2401450A1 (en) 1974-07-18
BE809831A (en) 1974-07-16
FR2213778B1 (en) 1978-01-06

Similar Documents

Publication Publication Date Title
Ullman et al. Dream telepathy: Experiments in nocturnal ESP.
FR2213778A1 (en) Adrenergics or hypoglycaemics for relieving skin disorders - e.g. psoriasis, dermatitis, skin carcinoma and acne in human beings
ZA89233B (en) Topical metronidazole formulations and therapeutic uses thereof
Cassileth et al. A psychological comparison of patients with malignant melanoma and other dermatologic disorders
NL170737C (en) PROCESS FOR PREPARING ESTERS OF ADRIAMYCIN AGAINST TUMORS, AND PREPARING MEDICINES WITH ANTI-TUMOR ACTIVITY.
Talkington et al. Reduction diets and aggression in institutionalized mentally retarded patients.
Xuan et al. Quality of life in psoriasis vietnamese patients treated with metformin in combination with methotrexate
Fenz et al. Effects of real and imagened threat of shock on GSR and heart rate as a function of trait anxiety.
Geagea et al. Response of a psychiatric patient to vitamin B12 therapy.
Flesch TOPICAL STEROIDS IN TREATMENT OF DERMATITIS
Ayres et al. Demodex folliculorum in rosacea
Jing et al. Effect of cordycepin on inhibiting delayed type hypersensitivity
Brunda et al. Suppression of murine natural killer cell activity by normal peritoneal macrophages
MOUL Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer
Sugawara Some remarks on homotopy groups of rotation groups
Izaki et al. Society Transactions Tohoku Dermatological Society The143rd: Meeting Aomori Bank, Aomori September21, 1958
FR2319355A1 (en) Compsns. for treating proliferative skin diseases - contain cycloheximide and a glucocorticoid antiinflammatory
Reiners Jr et al. 12-O-tetradecanoylphorbol-13-acetate-mediated systemic co-promotion in the murine skin multistage carcinogenesis protocol
Fachet et al. Lipid peroxidation and SOD activity in liver and membrane-microviscosity of macrophages in lentinan-treated tumor-bearing mice
USD193992S (en) Data collector cabinet
USD219441S (en) Metal wheel
Zhong et al. Chronopharmacology of Gemcitabine in the Treatment of Non-small Cell Lung Cancer
GB1066885A (en) Therapeutic agent and compositions having the inhibitory action for ª‰-glucuronidase and method of inhibiting ª‰-glucuronidase
Janusz et al. Isolation of a unit ligand for β-glucan receptors of human monocytes
Rozman et al. Comparative double placebo experiment of meclocycline and erythomycin in treatment of papulopustular acne.

Legal Events

Date Code Title Description
ST Notification of lapse